Skip to main content
SpringerLink
Log in

Changes are required to help community pharmacists become more involved in reporting medication safety issues

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Although community pharmacists are in a position to identify, record and report medication safety incidents, pharmacovigilance reporting rates by pharmacists are currently low. Changes within the pharmacy profession and to existing healthcare structures should help develop a culture that incorporates regular reporting of medication safety issues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rutter P, Borwn D, Howard J, et al. Pharmacists in pharmacovigilance: can increased diagnotic opportunity in community settings translate to better vigilance? Drug Saf. 2014;37(7):465–9.

    Article  PubMed  Google Scholar 

  2. Brown D, Portlock J, Rutter P. Services to support the healthy living pharmacy: a literature review. Int J Clin Pharm. 2012;34(3):399–409.

    Article  PubMed  Google Scholar 

  3. Stewart D, MacLure K, Paudyal V, et al. Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm. 2013;35(2):268–74.

    Article  PubMed  Google Scholar 

  4. Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, et al. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317–28.

    Article  CAS  PubMed  Google Scholar 

  5. Kroger E, Moisan J, Gregoire JP. Billing for cognitive services: understanding Quebec pharmacists’ behaviour. Ann Pharmacother. 2000;34(3):309–16.

    Article  CAS  PubMed  Google Scholar 

  6. Chan P, Grindrod KA, Bougher D, et al. A systematic review of remuneration systems for clinical pharmacy services. Can Pharm J. 2009;141(2):102–12.

    Article  Google Scholar 

  7. Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143(1):37–42.

    Article  Google Scholar 

  8. Austin Z, Gregory PAM, Martin JC. Negotiation of interprofessional culture shock: the experiences of pharmacists who become physicians. J Interprof Care. 2007;21(1):83–93.

    Article  PubMed  Google Scholar 

  9. Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.

    Article  PubMed  Google Scholar 

  10. Jadeja M, McCreedy C. Positive effect of new medicine service on community yellow card reporting. Pharm J. 2012;289:159.

    Google Scholar 

  11. Richardson E, Pollock AM. Community pharmacy: moving from dispensing to diagnosis and treatment. Br Med J. 2010;340:c2298.

    Article  Google Scholar 

Download references

Disclosure

This article was adapted from Drug Safety 2014;37(7):465–9 [1] by salaried employees of Adis/Springer, and was not supported by any external funding.

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Changes are required to help community pharmacists become more involved in reporting medication safety issues. Drugs Ther Perspect 31, 165–166 (2015). https://doi.org/10.1007/s40267-015-0186-0

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-015-0186-0

    Search

    Navigation